Trial Profile

Safety of sumatriptan in combination with lithium for treatment of cluster headache, Pilot Study,Phase II

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 14 Sep 2013

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lithium (Primary) ; Sumatriptan (Primary)
Indications Cluster headache
Focus Adverse reactions

Most Recent Events

13 Sep 2013 Planned end date changed from 27 Apr 2015 to 26 May 2014 as reported by European Clinical Trials Database record.
13 Sep 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
28 Jul 2012 Actual initiation date changed from 26 May 2010 to 27 Dec 2010 as reported by EudraCT.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com